RESUMO
BACKGROUND AND AIM: High dose brachytherapy using a non sealed 188Re-resin (Rhenium-SCT®, Oncobeta® GmbH, Munich, Germany) is a treatment option for non-melanoma skin cancer (NMSC). The aim of this prospective study was to assess the efficacy and the safety of a single application of Rhenium-SCT® in NMSC. MATERIALS AND METHOD: Fifty consecutive patients (15F, 35 M, range of age 56-97, mean 81) showing 60 histologically proven NMSCs were enrolled and treated with the Rhenium-SCT® between October 2017 and January 2020. Lesions were located on the face, ears, nose or scalp (n = 46), extremities (n = 9), and trunk (n = 5). Mean surface areas were 7.0 cm2 (1-36 cm2), mean thickness invasion was 1.1 mm (0.2-2.5 mm), and mean treatment time was 79 min (21-85 min). Superficial, mean, and target absorbed dose were 185 Gy, 63 Gy, and 31 Gy respectively. Patients were followed-up at 14, 30, 60, 90, and 180 days posttreatment, when dermoscopy and biopsy were performed. Mean follow-up was 20 months (range 3-33 months). Early skin toxicity was classified according to Common Terminology Criteria for Adverse Events (CTCAE). Cosmetic results were evaluated after at least 12 months according to Radiation Therapy Oncology Group (RTOG) scale. RESULTS: At 6 months follow-up, histology and dermoscopy were available for 54/60 lesions, of which 53/54 (98%) completely responded. One patient showed a 1-cm2 residual lesion that was subsequently surgically excised. Twelve months after treatment, 41/41 evaluable lesions were free from relapse. Twenty four months after treatment, 23/24 evaluable lesions were free of relapse. In 56/60 lesions early side effects, resolving within 32 days were classified as grades 1-2 (CTCAE). In the remaining 4/60 lesions, these findings were classified as grade 3 (CTCAE) and lasted up to 8-12 weeks but all resolved within 90 days. After at least 12 months (12-33 months), cosmetic results were excellent (30 lesions) or good (11 lesions). CONCLUSION: High dose brachytherapy with Rhenium-SCT® is a noninvasive, reasonably safe, easy to perform, effective and well-tolerated approach to treat NMSCs, and it seems to be a useful alternative option when surgery or radiation therapy are difficult to perform or not recommended. In our population 98% of the treated lesions resolved completely after a single application and only one relapsed after 2 years. Larger patients' population and longer follow-up are needed to confirm these preliminary data and to find the optimal dose to administer in order to achieve complete response without significant side effects.
Assuntos
Braquiterapia , Rênio , Neoplasias Cutâneas , Idoso , Idoso de 80 Anos ou mais , Braquiterapia/efeitos adversos , Alemanha , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Estudos Prospectivos , Rênio/uso terapêutico , Neoplasias Cutâneas/radioterapiaAssuntos
Alopecia em Áreas/classificação , Adulto , Biópsia , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Couro CabeludoAssuntos
Carcinoma de Célula de Merkel/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Célula de Merkel/diagnóstico por imagem , Carcinoma de Célula de Merkel/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Taxa de SobrevidaAssuntos
Doença de Crohn/diagnóstico , Granuloma/diagnóstico , Granuloma/tratamento farmacológico , Sarcoidose/diagnóstico , Vulvite/diagnóstico , Vulvite/tratamento farmacológico , Antibacterianos/uso terapêutico , Antifúngicos/uso terapêutico , Diagnóstico Diferencial , Quimioterapia Combinada , Econazol/uso terapêutico , Feminino , Ácido Fusídico/uso terapêutico , Granuloma/complicações , Humanos , Limeciclina/uso terapêutico , Pessoa de Meia-Idade , Triancinolona/uso terapêutico , Vulvite/complicaçõesRESUMO
Oral pigmentations (OPs) are often neglected, although a meticulous examination of the oral cavity is important not only in the diagnosis of oral melanoma, but also for the detection of important clinical findings that may indicate the presence of a systemic disease. OPs may be classified into two major groups on the basis of their clinical appearance: focal and diffuse pigmentations, even though this distinction may not appear so limpid in some cases. The former include amalgam tattoo, melanocytic nevi, melanoacanthoma and melanosis, while the latter include physiological/racial pigmentations, smoker's melanosis, drug-induced hyperpigmentations, postinflammatory hyperpigmentations and OPs associated with systemic diseases. We will discuss the most frequent OPs and the differential diagnosis with oral mucosal melanoma (OMM), underlining the most frequent lesions that need to undergo a bioptic examination and lesions that could be proposed for a sequential follow-up.
Assuntos
Hiperpigmentação/diagnóstico , Melanoma/diagnóstico , Melanoma/patologia , Neoplasias Bucais/diagnóstico , Neoplasias Bucais/patologia , Nevo Pigmentado/diagnóstico , Acantoma/diagnóstico , Acantoma/patologia , Biópsia , Diagnóstico Diferencial , Humanos , Hiperpigmentação/patologia , Melanose/diagnóstico , Melanose/patologia , Mucosa Bucal/patologia , Nevo Pigmentado/patologiaAssuntos
Carcinoma Basocelular/cirurgia , Carcinoma de Células Escamosas/cirurgia , Microcirurgia/métodos , Neoplasias Cutâneas/cirurgia , Adulto , Idoso de 80 Anos ou mais , Aminoquinolinas/administração & dosagem , Antineoplásicos/administração & dosagem , Carcinoma Basocelular/patologia , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/patologia , Terapia Combinada , Seguimentos , Humanos , Imiquimode , Masculino , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologiaRESUMO
Previous studies have reported positive effects of low-level laser therapy (LLLT) on bone healing. This study evaluated the effects of LLLT on peri-implant healing in vivo. Thirty-two rabbits had their mandibular left incisors removed, followed by immediate insertion of a dental implant into the fresh socket. Animals were assigned randomly to four groups: control (non-irradiated) or LLLT at three different doses per session: 5J/cm(2), 10J/cm(2), and 20J/cm(2). A GaAlAs laser (830nm, 50mW) was applied every 48h for 13 days, starting immediately after surgery. The implant stability quotient (ISQ) was measured using resonance frequency analysis upon implant insertion and immediately after death, 30 days after the last application. Tissues were prepared for scanning electron microscopy (SEM) and stereology. Variables measured were bone-implant contact (BIC) and bone neoformation within implant threads at three different sites. The results showed better ISQ for the 20J/cm(2) group (P=0.003). BIC values were significantly higher (P<0.05) in the 20J/cm(2) group, on both SEM and stereology. Bone area values were better in the 10J/cm(2) (P=0.036) and 20J/cm(2) (P=0.016) groups compared to the control group. Under these conditions, LLLT enhanced peri-implant bone repair, improving stability, BIC, and bone neoformation. The findings support and suggest parameters for the design of clinical trials using LLLT after implant placement.
Assuntos
Implantação Dentária Endóssea/métodos , Implantes Dentários , Terapia com Luz de Baixa Intensidade/métodos , Osteogênese/efeitos da radiação , Cicatrização/efeitos da radiação , Animais , Masculino , Mandíbula/cirurgia , Microscopia Eletrônica de Varredura , Coelhos , Alvéolo Dental/cirurgiaRESUMO
AIM: Superficial acral fibromyxoma (SAFM) is a rare soft tissue tumor, recently delineated and documentated as a separate entity. We report 12 cases of SAFM observed in our department from June 2004 to June 2010 and highlight pathological features and differential diagnosis. METHODS: Radiographic examination of the affected digit was performed in all patients. All the tumors were surgically excised under local anesthesia. Follow-up was made every 6-8 months for a maximum period of five years. RESULTS: The patients consisted of 8 men and 4 women, age range 28-76 years (mean 51), presenting with a solitary mass or nodule located in the toes and fingers. Histologically the lesions were well circumscribed dermal nodules composed of stellate and spindle cells, arranged in a myxoid matrix. Very low grade atypia and a few mitotic figures were found in only one case. Neoplastic cells showed immunoreactivity for CD34 (12 patients). In contrast focally positive or negative staining was shown for the epithelial membrane antigen (EMA) and CD 99. Actin, S100 protein, HMB45 and cytokeratin were negative. In three cases marked hyperkeratosis and acanthosis of the epidermis was present. Pathological analysis confirmed the diagnosis of superficial acral fibromyxoma. No recurrences were observed even in a long term, 2-5 year follow-up. CONCLUSION: Complete surgical excision of the tumors and a careful follow-up is suggested, despite the benign course previously reported.
Assuntos
Fibroma/patologia , Dedos/patologia , Doenças da Unha/patologia , Neoplasias de Tecidos Moles/patologia , Dedos do Pé/patologia , Adulto , Idoso , Biomarcadores Tumorais , Diagnóstico Tardio , Dermatofibrossarcoma/diagnóstico , Diagnóstico Diferencial , Feminino , Fibroma/química , Fibroma/diagnóstico , Fibroma/imunologia , Fibroma/cirurgia , Dedos/diagnóstico por imagem , Dedos/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Doenças da Unha/diagnóstico , Doenças da Unha/imunologia , Doenças da Unha/cirurgia , Radiografia , Neoplasias de Tecidos Moles/química , Neoplasias de Tecidos Moles/diagnóstico , Neoplasias de Tecidos Moles/imunologia , Neoplasias de Tecidos Moles/cirurgia , Dedos do Pé/diagnóstico por imagem , Dedos do Pé/cirurgiaRESUMO
Temporomandibular joint (TMJ) pseudoankylosis is characterized by limited mouth opening and mandibular movements, resulting from factors outside the joint. The authors present a case of TMJ pseudoankylosis caused by congenital zygomatic malformation and hyperplasia of the coronoid process. Treatment with coronoidectomy and postoperative physiotherapy achieved favorable results.
Assuntos
Anquilose/etiologia , Transtornos da Articulação Temporomandibular/etiologia , Zigoma/anormalidades , Terapia por Exercício , Feminino , Humanos , Hiperplasia , Mandíbula/patologia , Mandíbula/cirurgia , Amplitude de Movimento Articular/fisiologia , Tomografia Computadorizada por Raios X , Adulto JovemRESUMO
Benzodiazepines of natural origin (NBZDs) have been found in human blood and brains as well as in medicinal plants and foods. In plasma and brain tissue there are i.e. diazepam and nordiazepam equal to commercial drugs but there are also other benzodiazepine-like compounds termed "endozepines", which act as agonists at the benzodiazepine receptors of central type (CBR). A synthetic pathway for the production of NBZDs has not yet been found, but it has been suggested that micro-organisms may synthesize molecules with benzodiazepine-like structures. Hence NBZDs could be of both endogenous and exogenous source and be considered as natural anxyolitic and sedative. Interestingly there are also natural compounds, such as the polypeptide Diazepam Binding Inhibitor (DBI) acting as an "inversive agonist" implicated in fair and panic disorders. It has been suggested that NBZDs may play a role in the pathogenesis of hepatic encephalopathy (HE). Multidirectional studies evaluated NBZDs levels (1) in the blood of normal subjects, of cirrhotic with or without HE and in commercial benzodiazepine consumers; (2) in the blood of cirrhotic treated or not with a non-absorbable antibiotic; (3) in several constituents of our diet. In conclusion, NBZDs increase sometime in cirrhotics with or without HE but they reach concentrations not higher than those found in commercial benzodiazepines consumers. Hence NBZDs must be considered as occasional precipitating factor of HE and benzodiazepine antagonists only symptomatic drugs. The finding that NBZDs may be in part synthesized by intestinal bacterial flora and in part constituent of our diet underlines the importance to feed cirrhotic patients with selected food.
Assuntos
Encéfalo/metabolismo , Encéfalo/fisiopatologia , Inibidor da Ligação a Diazepam/metabolismo , Encefalopatia Hepática/metabolismo , Encefalopatia Hepática/fisiopatologia , Receptores de GABA-A/metabolismo , Animais , Ansiolíticos/metabolismo , Bactérias/química , Bactérias/metabolismo , Alimentos Formulados/normas , Antagonistas de Receptores de GABA-A , Humanos , Ligantes , Extratos Vegetais/metabolismo , Extratos Vegetais/farmacologiaRESUMO
Correction of maxillary transverse deficiencies is a common procedure in adult patients presenting dentofacial anomalies. Nasal characteristics of these patients, as well as the effects of these procedures upon nasal patency, have not been well described yet. In the present study, measurements performed by acoustic rhinometry and frontal cephalometry in 13 patients presenting maxillary deficiencies, before and after surgically assisted maxillary expansion (SARME), were compared with those of 10 individuals with normal dentofacial characteristics and without nasal symptoms. The variables analysed were minor cross-sectional area (MCA) and nasal volume, maxillomandibular transverse index and nasal and maxillary width. The results showed a smaller transverse width and MCA in the patients as compared with normal controls. All measurements showed a tendency to increase after SARME. The nasal volumes did not differ. The nasal width showed wide variation. There was no correlation among the variables. Patients presenting maxillary transverse deficiency seem to have lower values for nasal MCA, with a tendency to increase after SARME.
Assuntos
Cefalometria/métodos , Maxila/cirurgia , Técnica de Expansão Palatina , Rinometria Acústica , Adulto , Anatomia Transversal , Suturas Cranianas/cirurgia , Arco Dental/patologia , Feminino , Seguimentos , Humanos , Processamento de Imagem Assistida por Computador , Masculino , Mandíbula/patologia , Maxila/anormalidades , Maxila/patologia , Cavidade Nasal/patologia , Nariz/patologia , Osteotomia/métodos , Técnica de Expansão Palatina/instrumentaçãoRESUMO
Vascular access (VA) for dialysis is defined as the 'Achilles heel', but also the 'Cinderella' of dialysis, indicating the poor consideration of the problem whether in the surgical environment, or in incomprehensible way in that nephrologic. It can only aspire to the definition 'Fundamental detail'. However, presupposed effective dialysis is a blood flow rate of 300-350 mL/min. Good VA must be easy to prepare, long lasting, free from complications, and aesthetically acceptable and economical. The arteriovenous fistula (AVF) of Cimino and Brescia, from 1966, represents the gold standard and the model of comparison for other systems, more technologically advanced. It must be programmed with an adapted margin (1-2 months) to allow maturation and access certainty for the first puncture, and never carried out sooner than 14 days from the operation. It is known from hemodynamic studies that the good functional flow of the new fistula can already regain 400-500 ml/min in the first week, with cardiological implications like the increase in cardiac throw, in ejection fraction and in the cardiac index. Health workers, patients and dialysis staff must follow a continuous educational program to protect the VA and avoid 'routine and absent-minded management', a basis for its premature failure. The nephrologist must take the responsibility upon himself not to carry out 'medical malpractice'. In the Dialysis Center of Mantova, the VA 'road map' previews all patients (young and old, affections from mono or pluropathology), first the fistula to the wrist, then the cephalic proximal. It follows the basilic vein transposition, the vascular graft to the arm or to the groin, as an alternative to peritoneal dialysis. The permanent central venous catheter (CVCp) is the last choice in patients with reduced life expectancy, heart failure, neoplastic patients with vascular patrimony destroyed by chemotherapy and ischemic lesions produced by the fistula. There were 180 afferent prevailing patients at the Mantova Dialysis Center . The natural fistula rate was 91%, grafts 7% and CVCps 2%. Between 2000 and 31 March 2004 we prepared 367 VAs. Average patient age was 65 yrs, range 20-90 yrs; 59% male and 41% female. Eighty-eight percent of operations were performed by the nephrologist (distal fistula, rescue and cephalic proximal) and 12% by the vascular surgeon (basilic vein transposition, graft in PTFE stretch to the arm and to the groin and permanent catheter in the jugular vein). The fistula with native veins was the better solution, the graft must be prepared after the exhaustion of natural possibilities, and the CVCp, for serious complications (inadequate flow and infections), must be the last alternative.
Assuntos
Cateterismo , Falência Renal Crônica/terapia , Diálise Renal/métodos , Ensaios Clínicos como Assunto , Humanos , Diálise Renal/efeitos adversos , Diálise Renal/normasRESUMO
Extracts from pods and leaves of carob (Ceratonia siliqua L.) were tested for their ability to inhibit cell proliferation of mouse hepatocellular carcinoma cell line (T1). The two extracts showed a marked alteration of T1 cell proliferation in a dose-related fashion reaching the maximal effect at 1 mg/ml. Moreover, we demonstrated that leaf and pod extracts were able to induce apoptosis in T1 cell lines after 24-h treatment mediating a direct activation of the caspase 3 pathway. HPLC analysis revealed the presence of gallic acid, (-) epigallocatechin-3-gallate and (-) epicatechin-3-gallate in pod and leaf extracts, compounds well known to exert antiproliferative effects. Their concentration reached 6.28 mg/g in carob leaves and 1.36 mg/g in carob pods extract. The discovery that carob pod and leaf extracts contained antiproliferative agents could be of practical importance in the development of functional foods and/or chemopreventive drugs.
Assuntos
Antineoplásicos Fitogênicos/farmacologia , Fabaceae/química , Flavonoides , Neoplasias Hepáticas/patologia , Extratos Vegetais/farmacologia , Animais , Apoptose/efeitos dos fármacos , Caspase 3 , Caspases/metabolismo , Divisão Celular/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , Relação Dose-Resposta a Droga , Neoplasias Hepáticas/tratamento farmacológico , Camundongos , Fenóis/farmacologia , Fitoterapia , Estruturas Vegetais/química , Polímeros/farmacologia , Polifenóis , Células Tumorais CultivadasAssuntos
Apoptose , Citocinas/metabolismo , Rejeição de Enxerto/terapia , Transplante de Coração/imunologia , Linfócitos/imunologia , Fotoferese , Adulto , Idoso , Feminino , Seguimentos , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/metabolismo , Humanos , Interferon gama/metabolismo , Interleucina-2/metabolismo , Interleucina-4/metabolismo , Interleucina-6/metabolismo , Linfócitos/metabolismo , Linfócitos/patologia , Masculino , Pessoa de Meia-Idade , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Increased number of peripheral benzodiazepine receptors (PBRs) have been found in some tumors outside the liver. The present study was to verify whether the PBR system is altered in hepatocellular carcinoma (HCC). The levels of endogenous benzodiazepine-like compounds (BZDs), measured by radioreceptor binding technique after HPLC purification and the endogenous ligand for PBRs, termed diazepam binding inhibitor (DBI), measured by radioimmunoassay utilizing a specific antibody for human DBI, were studied in the blood of 15 normal subjects, 12 liver cirrhosis and 10 patients with HCC. The levels of BZDs in serum were increased hundred fold in liver cirrhosis patients and slightly elevated in HCC patients. DBI was found to be increased in HCC patients. The binding recognition sites for PBRs (Bmax) were increased 4 to 7 fold in HCC tissue in comparison with that found in non-tumoral liver tissue (NTLT). On the contrary the concentrations of DBI were found to be significantly decreased in HCC tissue in comparison with the respective NTLT. These results seem to suggest an implication of PBRs and of their putative endogenous ligands in the metabolism of these neoplastic cells and possibly in their proliferation. The up-regulation of PBRs found in HCC tissue seems to indicate an increased functional activity of these receptors and opens up the possibility of new pharmacological and diagnostic approaches while the changes in the circulating endogenous ligands for the above receptors might be envisaged as early markers of tumorigenesis in liver cirrhosis.
Assuntos
Carcinoma Hepatocelular/química , Neoplasias Hepáticas/química , Receptores de GABA-A/análise , Adulto , Idoso , Benzodiazepinas/sangue , Proteínas de Transporte/sangue , Inibidor da Ligação a Diazepam , Feminino , Humanos , Fígado/química , Masculino , Pessoa de Meia-Idade , Regulação para CimaRESUMO
Cholesterol is used by cells for biosynthetic processes and for steroid synthesis. Although the role of cholesterol in tumorigenesis is not clear it is known that steroids are important factors in human carcinogenesis. A polypeptide, diazepam binding inhibitor (DBI), which is an endogenous ligand for peripheral benzodiazepine receptors enhances steroidigenesis by promoting cholesterol delivery to the inner mitochondrial membrane which represents the rate-limiting step of steroid biosynthesis. We have assayed the total cholesterol (TC) and the DBI plasma concentrations in patients with liver cirrhosis complicated by hepatocellular carcinoma (HCC) in comparison with those of uncomplicated liver cirrhosis. TC and DBI levels have been studied in 73 cirrhotic patients and in 23 patients with HCC. Both TC and DBI levels were higher in HCC patients when compared with age, sex and Child-Pugh class matched cirrhotic controls. The values (mean+/-S.D.) in patients in Child-Pugh class B and C with and without HCC were respectively 128+/-30 mg/dl vs. 106+/-27 mg/dl (P < 0.01) and 2.05+/-0.78 pmol/ml vs. 0.78+/-0.84 pmol/ml (P < 0.0001). The data may be the result of the metabolic influence of tumors that enhances steroid biosynthesis during tumor proliferation.